Online citations, reference lists, and bibliographies.
← Back to Search

Past Trends And Future Prediction Of Mesothelioma Incidence In An Industrialized Area Of Italy, The Veneto Region.

P. Girardi, V. Bressan, E. Merler
Published 2014 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
BACKGROUND Malignant Mesothelioma (MM) is so associated with (professional, familial or environmental) asbestos exposure that trends in incidence and mortality parallel, after 30-40 years, the trend in asbestos consumption. In recent decades, the industrialized countries have witnessed a steady growth of pleural MM (MPM), following a stabilization or decline in rates in the countries that first adopted restrictive policies. The aim of this study was to evaluate the temporal variations of pleural MM incidence in the Veneto Region of Italy in the period 1987-2010. METHODS We included only MPM with histological or cytological diagnosis. Age-Period-Cohort (APC) models were used to assess the trend in the incidence of MPM in both genders. Future predictions were evaluated by using a Bayesian APC model. RESULTS In the period 1987-2010, 1600 MPMs have occurred. We observe a positive trend in the incidence in the whole period considered. The APC model showed that in both genders the cohort at higher risk is the one born between the years 1940-1945. Future projections indicate that the trend will decrease after the incidence peak of 2010; yet 1234 men are expected to develop a mesothelioma between 2011 and 2026. Among women, the future MPM rates will be stable or slightly decreasing. CONCLUSIONS The asbestos ban introduced in Italy in the year 1992 as a prospective result will certainly determine a decreasing incidence. However, the extremely long latency of MPM means that its influence is not yet observable.
This paper references
10.1183/09031936.96.09091932
The epidemiology of mesothelioma in historical context.
J. C. Mcdonald (1996)
10.1186/1471-2407-13-528
Pleural cancer mortality in Spain: time-trends and updating of predictions up to 2020
G. López-Abente (2013)
10.1002/AJIM.20246
Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model.
Takehiko Murayama (2006)
10.1080/10408440903044928
Time trend of mesothelioma incidence in the United States and projection of future cases: An update based on SEER data for 1973 through 2005
B. Price (2009)
10.1136/oem.60.1.50
Update of predictions of mortality from pleural mesothelioma in the Netherlands
O. Segura (2003)
10.1016/J.LUNGCAN.2007.10.012
Lung cancer mortality in France. Trend analysis and projection between 1975 and 2012, using a Bayesian age-period-cohort model.
D. Eilstein (2008)
10.1002/SIM.4780060405
Models for temporal variation in cancer rates. I: Age-period and age-cohort models.
D. Clayton (1987)
10.1183/09031936.00168111
Mesothelioma incidence projections in South East England
S. P. Riaz (2012)
10.1002/GEPI.10291
Bayesian trio models for association in the presence of genotyping errors
L. Bernardinelli (2004)
10.1179/oeh.2003.9.3.206
Malignant Mesothelioma in Australia, 1945–2002
J. Leigh (2003)
10.2486/INDHEALTH.MS1184
Future trends of mesothelioma mortality in Japan based on a risk function.
Tomoya Myojin (2012)
Lung cancer mortality in France. Trend analysis and projection between 1975 and 2012, using a Bayesian age-periodcohort model. Lung Cancer 2008;59:282–90
D Eilstein (2008)
10.1002/ijc.26229
Pleural malignant mesothelioma epidemic: Incidence, modalities of asbestos exposure and occupations involved from the Italian National Register
A. Marinaccio (2012)
10.1023/A:1026300619747
Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends
F. Montanaro (2004)
10.1002/ijc.24711
Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005
N. Le Stang (2010)
10.1002/ijc.11357
Incidence trends of mesothelioma in Norway, 1965–1999
B. Ulvestad (2003)
10.1136/oem.2007.034769
Mesothelioma mortality in men: trends during 1977–2001 and projections for 2002–2016 in Spain
S. Pitarque (2007)
10.18637/JSS.V021.I08
Bayesian Age-Period-Cohort Modeling and Prediction - BAMP
V. Schmid (2007)
10.1136/jcp.48.7.691-a
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
A. Zuckerman (2010)
10.1097/JTO.0b013e318275b346
Incidence and Survival of Malignant Pleural Mesothelioma in Norway: A Population-Based Study of 1686 Cases
Å. Helland (2012)
10.1038/sj.bjc.6602307
The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050
J. Hodgson (2005)
10.3978/j.issn.2225-319X.2012.11.04
Malignant pleural mesothelioma: an epidemiological perspective.
Benjamin M. Robinson (2012)
10.1002/ijc.20820
Predictions of mortality from pleural mesothelioma in Italy: A model based on asbestos consumption figures supports results from age‐period‐cohort models
A. Marinaccio (2005)
10.1002/ijc.10806
Mesothelioma incidence seems to have leveled off in Sweden
K. Hemminki (2003)
10.2471/BLT.11.086678
Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008.
V. Delgermaa (2011)
10.1016/J.THORSURG.2004.06.009
Malignant pleural mesothelioma: overview of the North American and European experience.
J. Kukreja (2004)
[Surveillance of malignant mesothelioma cases and definition of asbestos exposure: 1997 ReNaM data].
M. Nesti (2003)
10.1097/00008469-200006000-00006
H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinoma: a case-control study.
U. Suleiman (2000)
R: A language and environment for statistical computing.
R. Team (2014)
10.1179/2049396712Y.0000000016
Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003–2008
S. Jane Henley (2013)
10.1111/j.1440-1843.2011.01975.x
Asbestos use and asbestos‐related diseases in Asia: Past, present and future
G. Le (2011)
10.1179/oeh.2006.12.1.9
Malignant Mesothelioma Mortality in the United States, 1999–2001
K. M. Bang (2006)
10.1016/S0140-6736(07)60412-7
Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis
Ro-Ting Lin (2007)
10.2307/2531004
The estimation of age, period and cohort effects for vital rates.
T. Holford (1983)
10.1136/oem.57.7.488
Future trends in mortality of French men from mesothelioma
A. Banaei (2000)
10.1016/S0022-510X(01)00572-X
Predicting secondary progression in relapsing–remitting multiple sclerosis: a Bayesian analysis
R. Bergamaschi (2001)
10.1097/00008469-200006000-00005
An age, period and cohort analysis of pleural cancer mortality in Europe.
C. la Vecchia (2000)
10.1002/SIM.2764
Age-period-cohort models for the Lexis diagram.
B. Carstensen (2007)
10.1038/sj.bjc.6605781
Projection of mesothelioma mortality in Britain using Bayesian methods
E. Tan (2010)
[Trends in mortality from primary pleural tumor and incidence of pleural mesothelioma in Italy: a particularly serious situation].
E. Merler (1999)
10.1093/BIOSTATISTICS/2.1.109
Projections of lung cancer mortality in West Germany: a case study in Bayesian prediction.
L. Knorr-Held (2001)
10.5271/SJWEH.520
Incidence rates of malignant mesothelioma in Denmark and predicted future number of cases among men.
J. Kjaergaard (2000)
10.1038/bjc.2012.112
Occupational cancer burden in Great Britain
L. Rushton (2012)
10.1038/sj.bjc.6690105
The European mesothelioma epidemic
J. Peto (1999)



This paper is referenced by
10.1016/j.scitotenv.2015.10.115
Predicting the mortality from asbestos-related diseases based on the amount of asbestos used and the effects of slate buildings in Korea.
S. Kim (2016)
10.3390/ijerph17020607
Predictions of Mortality from Pleural Mesothelioma in Italy After the Ban of Asbestos Use
E. Oddone (2020)
10.1136/oemed-2016-103652
Incidence of mesothelioma in Lombardy, Italy: exposure to asbestos, time patterns and future projections
C. Mensi (2016)
10.1007/s40572-016-0109-9
Recent Scientific Evidence Regarding Asbestos Use and Health Consequences of Asbestos Exposure
M. Valenzuela (2016)
10.1016/j.jtho.2017.04.002
Epidemiology of Environmental Exposure and Malignant Mesothelioma.
Bian Liu (2017)
10.4225/50/57CDFEBB71B93
Review of the effectiveness of predictive models for mesothelioma to identify lessons for asbestos-related policy
Alison Reid (2016)
10.1007/s10552-016-0838-y
Incidence of malignant mesothelioma in Germany 2009–2013
Martin Lehnert (2016)
10.1136/oemed-2015-103382
Residual fibre lung burden among patients with pleural mesothelioma who have been occupationally exposed to asbestos
E. Merler (2016)
10.1186/s10194-020-01108-3
Pain rates in general population for the period 1991–2015 and 10-years prediction: results from a multi-continent age-period-cohort analysis
D. Guido (2020)
10.1016/j.canep.2015.08.007
The next mesothelioma wave: mortality trends and forecast to 2030 in Brazil.
E. Algranti (2015)
Global and regional burden of cancer in 2016 arising from occupational exposure to selected carcinogens: A systematic analysis for the Global Burden of Disease Study 2016
L. Morawska (2020)
10.1183/2312508x.10034019
The global perspective of occupational lung disease
M. Jeebhay (2020)
10.1016/j.aogh.2014.10.002
Occupational and environmental exposures and cancers in developing countries.
D. Hashim (2014)
10.1265/jjh.73.338
[Gender Differences in Projected Life Expectancy in Japan (2023-2047) Determined by Bayesian Age-Period-Cohort Analysis].
H. Uchida (2018)
10.1136/oemed-2019-106012
Global and regional burden of cancer in 2016 arising from occupational exposure to selected carcinogens: a systematic analysis for the Global Burden of Disease Study 2016
Tim Lesley Kyle Sally Kurt Degu Omar Dilaram Mohsen Fa Driscoll Rushton Steenland Hutchings Straif Abate (2020)
Clinicopathologic and Survival Characteristics of Malignant Pleural Mesothelioma Registered in Hospital Cancer Registry
K. Najmi (2014)
III Italian Consensus Conference on Malignant Mesothelioma of the Pleura. Epidemiology, Public Health and Occupational Medicine related issues.
C. Magnani (2015)
Semantic Scholar Logo Some data provided by SemanticScholar